Search

Issue
Title
Authors
Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
Grechukhina K.S., Zhukova L.G.
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E.
New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors
Laktionov K.K., Reutova E.V., Nelyubina L.A., Pitkevich M.Y., Okruzhnova M.A., Ardzinba M.S., Yudin D.I., Demidova I.A., Zaretsky A.R.
Clinical cases of treatment of patients with advanced hepatocellular carcinoma
Petkau V.V., Gladkov O.A., Filatov P.N., Raigorodskii M.V., Tarkhanov A.A., Klimushkin A.V., Nikitina L.Y.
Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Khokhlova S.V.
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Kolbin A.S., Mosikyan A.A., Kurilev A.A., Balykina Y.E., Proskurin M.A.
Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
Vladimirova L.Y.
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E.V., Zhukova L.G.
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
Multimodal approach to the treatment of hepatocellular carcinoma
Skipenko O.G., Chekunov D.A., Shatverian G.A., Bagmet N.N., Sekacheva M.I., Polyakov R.S., Bedzhanyan A.L., Abdullaev A.G., Moysyuk Y.G.
Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
Artamonova E.V., Manziuk L.V.
Surgical results in patients 75 years and older with gastric cancer
Rokhoev G.A., Stilidi I.S., Nered S.N.
High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Seryakov A.P., Ovchinnikova L.K., Zabelin M.V., Yakubov T.Z., Sidorov D.B., Ovchinnikov M.V.
The role of tamoxifen in the therapy of metastatic ovarian cancer
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R.
Problem of iron-deficiency anemia in patients with cancers: practice in using iron-containing drugs
Snegovoy A.V.
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
Pignata S.
New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
Artamonova E.V., Manzyuk L.V.
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
Artamonova E.V.
HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy
Ognerubova I.N.
Molekulyarno-biologicheskie markery v khimioterapevticheskom lechenii metastaticheskogo kolorektal'nogo raka
Kuznetsova E.A., Eropkin P.V., Kashnikov V.N.
Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy
Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Semiglazov V.F., Semiglazov V.V.
Sostoyanie zabolevaemosti, smertnosti, onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh gastroenterologicheskoy lokalizatsii v Navoiyskoy oblasti Respubliki Uzbekistan
Kudryavtsev I.Y., Kerimov R.A.
Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy
Brzhezovskiy V.Z., Lyubaev V.L., Kochurina G.Y., Subramanian S.
Rak cherveobraznogo otrostka (osobennosti klinicheskogo techeniya, diagnostiki i lecheniya)
Komov D.V., Kolesova O.V., Ivanova E.A.
Endoskopicheskaya diagnostika i lazernaya destruktsiya raka gortani
Ungiadze G.V., Poddubnyy B.K., Belousova N.V., Kontsevaya A.Y.
Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
Sovremennye standarty lecheniya raka yaichnikov
Kharitonova T.V.
Long-term aesthetic outcomes of reconstructive surgeries with endoprosthetics for breast cancer: A review
Khomidi U.K., Vlasova M.Y., Saribekyan E.K., Zikiryakhodzhaev A.D., Khakimova S.G., Khakimova G.G., Kodzoeva D.B.
The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report
Slashchuk K.Y., Reinberg M.V., Serzhenko S.S., Sheremeta M.S., Nikiforovich P.A.
Predictive modeling of the probability of gynecological complications of tamoxifen therapy: A prospective study
Golubenko E.O., Savelyeva M.I., Korennaya V.V., Podzolkova N.M., Valiev T.T.
EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case
Magamedova O.R., Oganesyan L.V., Feoktistova P.S., Feidorov I.Y.
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yudina E.V.
Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Melnikov V.D.
Colon cancer-induced sarcopenia: clinical and radiological correlations
Lyadov V.K., Fedorinov D.S., Lyadova M.A., Khristenko E.A., Boldyreva T.S., Galkin V.N.
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study
Zhurman V.N.
Updates in urologic oncology guidelines: renal cell carcinoma. A review
Volkova M.I., Nosov D.A., Alekseev B.Y.
Influence of radiation therapy on the development of complications in single-stage autologous breast reconstruction with a DIEP-flap in breast cancer patients: a retrospective study
Duadze I.S., Kaprin A.D., Zikiryakhodzhaev A.D., Reshetov I.V., Usov F.N., Rasskazova E.A., Sukhotko A.S., Starkova M.V., Bagdasarova D.V., Dzhabrailova D.S., Khakimova S.G.
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I.V., Chubenko V.A.
Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report
Ognerubov N.A., Antipova T.S.
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research
Kolomejtseva A.A., Bokova S.E.
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Shlivko I.L., Garanina O.E., Artamonova E.V., Ganshina I.P., Zhukova L.G., Koroleva I.A., Michenko A.V., Semiglazova T.Y., Filonenko D.A.
Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Lienhard D.A.
Synchronous thyroid gland metastases from breast cancer. Case reports
Ognerubov N.A., Antipova T.S., Palkina E.E.
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
Breast cancer
Zhukova L.G., Andreeva I.I., Zavalishina L.E., Zakiriakhodzhaev A.D., Koroleva I.A., Nazarenko A.V., Paltuev R.M., Parokonnaia A.A., Petrovskii A.V., Portnoi S.M., Semiglazov V.F., Semiglazova T.I., Stenina M.B., Stepanova A.M., Trofimova O.P., Tyulyandin S.A., Frank G.A., Frolova M.A., Shatova I.S., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I.P., Gordeeva O.O., Manukian M.S.
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N.A., Antipova T.S., Gumareva G.E.
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Reutova E.V., Ardzinba M.S., Arzumanian A.L.
The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
Modern ultrasound diagnostics for locally advanced cervical cancer
Ovodenko D.L., Khabas G.N., Makarova A.S., Pirogova M.S., Seregin A.A., Golitsyna Y.S., Ashrafyan L.A.
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation
Kolomeytseva A.A., Yemelyanova G.S., Gorbunova V.A., Orel N.F., Perevodchikova N.I., Bokhyan V.Y., Fedenko A.A.
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
Tracheal and bronchial plastic resection in patients with lung cancer
Khvastunov R.A., Usachev A.A.
The role of regorafenib in the treatment of metastatic colorectal cancer
Tryakin A.A.
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F.
Systemic drug therapy of metastatic pancreatic cancer
Pokataev I.A., Tyulyandin S.A.
The results of Epidemiological HER2 screening program in patients with breast cancer in 2014
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case
Bisovskaya Y.V., Breder V.V., Medvedeva B.M., Gorbunova V.A.
The effect of combinated treatment of a metastatic HER2-positive stomach cancer
Khvastunov R.A., Nenarokomov A.Y., Tolstopiatov S.E., Babina K.G.
Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Jackisch C., Llombart-Cussac A.
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC
Orlov S.V.
Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka
Tlish E.K.
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results
Garbuzov M.I.
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen'
Tryakin A.A.
Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
Znachenie klinicheskikh i molekulyarno-geneticheskikh prediktorov otveta na terapiyu ingibitorami tirozinkinazy v vybore lechebnoy taktiki pri nemelkokletochnom rake legkogo
Smolin A.V., Konev A.V., Solovey T.G., Nikolaeva S.N., Shamanskaya Y.E.
Vliyanie immunomodulyatora Galavit na immunologicheskiy status bol'nykh nemelkokletochnym rakom legkogo II-III stadii
Vel'sher L.Z., Gabuniya Z.R., Grishina T.I., Germanov A.B., Korobkova L.I., Platonov D.A., Argun V.M., Gens G.P.
Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
Komarova V.P., Komarova L.E., Poddubnaya I.V.
Sovremennaya taktika ad\"yuvantnoy lekarstvennoy terapii bol'nykh operabel'nym (rannim) rakom molochnoy zhelezy
Perevodchikova N.I.
Puti uluchsheniya neposredstvennykh rezul'tatov khirurgicheskogo lecheniya yukstakardial'nogo raka
Khvastunov R.A., Shereshkov A.Y., Ivanov A.I., Mudryy A.Y.
Preventivnaya limfodissektsiya pri rake gortani i gortanoglotki T3-4N0M0
Boykov V.P.
Sovremennye vozmozhnosti lecheniya kolorektal'nogo raka
Barsukov Y.A., Knysh V.I.
Osnovnye aspekty primeneniya bisfosfonatov v onkologii
Kondrat'eva A.P.
Znachenie odnomomentnykh operatsiy pri kostnykh metastazakh raka pochki s intrakranial'nym rasprostraneniem
Karakhan V.B., Matveev B.P., Fu R.G., Aleshin V.A., Krat V.B.
Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review
Grechukhina K.S., Sukhova M.V., Kolyago E.M., Filonenko D.A., Zhukova L.G.
Analysis of the survival rate of patients with ovarian cancer of stages I–IV: A retrospective study
Zhurman V.N.
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
Pokataev I.A., Stativko O.A., Volkova M.I., Fedorova A.N., Zueva E.V., Ibragimova M.R., Tsareva E.V., Antonova T.G., Sinitsyna O.R., Cherniaev V.A., Gridneva Y.V., Oskarev A.V., Galkin V.N.
Isolated metastasis to the scalp in occult breast cancer: a clinical case
Ognerubov N.A., Sergeev R.S., Hizhnyak A.O., Ognerubova M.A., Dzhabrailov M.A.
Correction of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report
Obukhova O.A., Dibirova P.A., Kurmukov I.A., Allakhverdiyan G.S., Shagina N.Y., Mustafina E.А., Knyazev R.I., Pajanidi J.G.
Solitary metastasis of colorectal cancer in the left adrenal gland 4 years after surgery on the primary tumor. Case report
Budurova M.D., Trifanov V.S., Kopylov V.V., Kuznetsova O.S., Chernichenko M.A., Poluektov S.I.
Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre
Potapov A.L., Аgababyan T.A., Dorozhkin A.D., Pimonova I.S., Nevolskikh A.A., Ivanov S.A., Kaprin A.D.
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study
Khatkov I.E., Semenov N.N., Izrailov R.E., Efanov M.G., Dalgatov K.D., Zhukova L.G.
Clinical case of complications of immunotherapy – encephalitis
Lyadova M.A., Kuchevskaya O.A., Kulikova E.A.
Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report
Grechukhina K.S., Vorontsova K.A., Filonenko D.A., Tyutyunnik P.S., Shchadrova V.V., Zhukova L.G.
Malignant refractory priapism in case of urothelial cancer. Case report
Ognerubov N.A., Antipova T.S.
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report
Orlov S.V., Baldin P.L., Diuzeva N.V., Krechetova A.V., Mordovskiy A.A., Moskovchenko A.N., Musaeva N.E., Romanchuk O.V.
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
Gastric cancer: Russian clinical guidelines
Besova N.S., Kalinin A.E., Nered S.N., Triakin A.A., Gamaiunov S.V., Kozlov N.A., Stilidi I.S., Karachun A.M., Kononets P.V., Malikhova O.A., Riabov A.B., Khomiakov V.M., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Nevol'skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil'mutdinova I.R., Eremushkin M.A., Ivanova G.E., Kondrat'eva K.O., Konchugova T.V., Krutov A.A., Obukhova O.A., Semiglazova T.I., Filonenko E.V., Khulamkhanova M.M., Romanov A.I.
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
Petkau V.V., Karimova A.A., Akishina Z.V.
Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M.I., Fatyanova A.S., Meretukov D.A., Zhilenkova A.V., Rusanov A.S., Rozhkov A.A., Guryanova A.A., Bagmet N.N.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.V.
Can any breast skin thickening be staged as T4?
Amosova V.A., Petrovskii A.V., Karpova M.S., Ponedel’nikova N.V., Frolova M.A.
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N.V., Artamonova E.V., Beloyartseva M.F., Volkova E.I., Ganshina I.P., Troshina E.A., Tjulandin S.A., Chubenko V.A.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.V.
Opportunities for metastatic triple negative breast cancer therapy
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
The use of regorafenib in colorectal cancer
Sekacheva M.I., Bagmet N.N., Guryanova A.A., Rashi D.A.
Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy
Abdurakhmanov D.T., Breder V.V., Bolotina L.V., Kosyrev V.I., Medvedeva B.M., Petkau V.V.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
Orlova R.V., Zhukova L.G., Ganshina I.P., Yukalchuk D.Y., Ponomarenko D.M., Beliak N.P., Gordeeva O.O., Erdniev S.P., Minasyan A.A., Dashkova A.A., Sopiya E.R., Sholokhova E.A., Gurochkin A.B.
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal
Glebovskaya V.V., Tkachev S.I., Ivanov S.M., Nazarenko A.V., Rasulov A.O., Gordeev S.S., Bulychkin P.V., Besova N.S., Barsukov U.A., Trofimova O.P., Borisova T.N., Timoshkina E.V.
Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Demidova I.A.
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
Khokhlova S.V.
Concerning selective neck dissections in oral squamous cell carcinoma
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
Male breast cancer: review of the literature
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.S.
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A.A., Ivanov S.A.
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.V.
Surgical stading local – cervical cancer incidence
Kargopolova M.V., Maximov S.Y., Berlev I.V., Boyarkina M.P., Meshkova I.E., Khadzhimba A.S., Novikov S.N., Krzhivitsky P.I., Ponomareva O.I., Urmancheeva A.F., Ivanzov A.O., Guseynov K.D., Vishinskaya E.A., Matveeva N.S.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I.I., Abakumova T.V., Gening T.P., Gening S.O.
Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni
Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii
Ad\"yuvantnoe lechenie raka tolstoy kishki
Artamonova E.V., Podregul'skiy K.E.
Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Myasnikova M.O.
Mesto UZT pri planirovanii lecheniya zlokachestvennykh epitelial'nykh opukholey yaichnikov
Chekalova M.A., Poddubnaya I.V., Mazyrko M.A., Sinitsina M.E.
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh kozhi v Navoiyskoy oblasti Respubliki Uzbekistan
Kudryavtsev I.Y., Aksel' E.M., Kerimov R.A.
Endoskopicheskaya semiotika i diagnostika limfom glotochnogo kol'tsa Pirogova-Val'deyera
Belousova N.V., Poddubnyy B.K., Ungiadze G.V., Arkhipov V.V., Gubin A.N.
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga
Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B.
Prognostic significance of androgen receptor expression in triple-negative breast cancer
Panchenko I.S., Panchenko S.V., Sharafutdinov M.G., Rodionov V.V., Kometova V.V., Burmenskaya O.V.
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
Ognerubov N.A., Barsukov S.V.
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review
Grechukhina K.S., Kalugin M.V., Prosvirnov A.A., Sukhova M.V., Zhukova L.G.
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"
Ryazhenov V.V., Orlov S.V., Ivakhnenko O.I.
Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series
Lyadov V.K., Moskalenko A.N., Britskaia N.N.
Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
Zhabina A.S., Moiseenko F.V., Volkov N.M., Abduloeva N.K., Moiseenko V.M.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I.V., Gligorov J., Zhukova L.G., Kovalenko E.I., Frolova M.A.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I.B., Snegovoy A.V., Grebennikova O.P., Sel’chuk V.Y., Palchinskaia O.V.
151 - 300 of 484 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».